MC1099A1 - Médicament à base d'un polypeptide - Google Patents

Médicament à base d'un polypeptide

Info

Publication number
MC1099A1
MC1099A1 MC761190A MC1190A MC1099A1 MC 1099 A1 MC1099 A1 MC 1099A1 MC 761190 A MC761190 A MC 761190A MC 1190 A MC1190 A MC 1190A MC 1099 A1 MC1099 A1 MC 1099A1
Authority
MC
Monaco
Prior art keywords
polypeptide
medicinal product
product according
app
paragraph
Prior art date
Application number
MC761190A
Other languages
English (en)
French (fr)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1099A1 publication Critical patent/MC1099A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MC761190A 1975-04-15 1976-04-14 Médicament à base d'un polypeptide MC1099A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15414/75A GB1560933A (en) 1975-04-15 1975-04-15 Biologically activy polypeptides

Publications (1)

Publication Number Publication Date
MC1099A1 true MC1099A1 (fr) 1977-02-04

Family

ID=10058726

Family Applications (1)

Application Number Title Priority Date Filing Date
MC761190A MC1099A1 (fr) 1975-04-15 1976-04-14 Médicament à base d'un polypeptide

Country Status (19)

Country Link
US (1) US4355025A (Direct)
JP (1) JPS51128414A (Direct)
AU (1) AU1306576A (Direct)
BE (1) BE840752A (Direct)
CA (1) CA1067822A (Direct)
DE (1) DE2616462A1 (Direct)
DK (1) DK175176A (Direct)
FI (1) FI761022A7 (Direct)
FR (1) FR2307541A1 (Direct)
GB (1) GB1560933A (Direct)
GR (1) GR59326B (Direct)
IE (1) IE43089B1 (Direct)
IL (1) IL49423A (Direct)
LU (1) LU74769A1 (Direct)
MC (1) MC1099A1 (Direct)
NL (1) NL7603972A (Direct)
NZ (1) NZ180604A (Direct)
SE (1) SE7604373L (Direct)
ZA (1) ZA762241B (Direct)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701441A (en) * 1985-02-11 1987-10-20 University Of Florida Methods and compositions for stimulation of appetite
US5395823A (en) * 1988-08-26 1995-03-07 Merrell Dow Pharmaceuticals Inc. Neuropeptide Y agonists and partial agonists
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
JP2005514008A (ja) * 2001-09-24 2005-05-19 オレゴン ヘルス アンド サイエンス ユニバーシティー 摂食行動を改変する薬剤をスクリーニングするための、弓状核におけるニューロンの評価方法
BR0212985A (pt) * 2001-09-24 2005-08-30 Imp College Innovations Ltd Uso de pyy ou de um agonista do mesmo na preparação de medicamentos para tratamento de distúrbios associados com excesso de peso
US8058233B2 (en) * 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
GB0300571D0 (en) * 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
GB0511986D0 (en) * 2005-06-13 2005-07-20 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
TWI428346B (zh) * 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH351565A (fr) * 1955-09-15 1961-01-31 Israeel Dr Alt Procédé de préparation de nouveaux composés à action thérapeutique, dérivant du suc pancréatique
FR1345565A (fr) * 1962-01-19 1963-12-13 Rolland Lab A Procédé pour l'obtention d'extraits totaux plus généralement orginaires de tissus viants
FR1407807A (fr) * 1964-06-25 1965-08-06 Comp Generale Electricite électrode pour pile à combustible
GB1381274A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
IE36225B1 (en) * 1971-01-28 1976-09-15 Nat Res Dev Improvements relating to insulin derivatives
GB1381273A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
FR2204409A1 (en) * 1972-10-27 1974-05-24 Palolab Pharmaceuti Als Isolation of biologically active protein - with influence on primary carbohy-drate metabolism and the urea cycle and used to treat uraemia inflammation and shock

Also Published As

Publication number Publication date
JPS51128414A (en) 1976-11-09
NL7603972A (nl) 1976-10-19
IL49423A0 (en) 1976-06-30
FR2307541A1 (fr) 1976-11-12
US4355025A (en) 1982-10-19
SE7604373L (sv) 1976-10-16
FI761022A7 (Direct) 1976-10-16
BE840752A (fr) 1976-10-14
DE2616462A1 (de) 1976-10-28
GR59326B (en) 1977-12-13
LU74769A1 (Direct) 1977-02-04
CA1067822A (en) 1979-12-11
AU1306576A (en) 1977-10-20
FR2307541B1 (Direct) 1979-06-29
IE43089B1 (en) 1980-12-17
NZ180604A (en) 1978-06-20
IE43089L (en) 1976-10-15
GB1560933A (en) 1980-02-13
DK175176A (da) 1976-10-16
ZA762241B (en) 1977-11-30
IL49423A (en) 1979-05-31

Similar Documents

Publication Publication Date Title
Reubi A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth
AU2011200663B2 (en) Exendin for treating diabetes and reducing body weight
EP0309100B1 (en) Use of amylin or CGRP for the treatment of diabetes mellitus
DE69219607T2 (de) Verfahren zur anregung der immunresponz
CA2365742C (en) Formulations for amylin agonist peptides
PT100629A (pt) Metodo para a estimulacao da resposta imune usando hormona de crescimento
JPH01121300A (ja) 乳汁に由来するポリペプチド成長因子
DE60005806T2 (de) Zusammensetzung auf basis gegensätzlich geladener polypeptide
FR2513125A1 (fr) Medicament curatif du deficit immunitaire
EP2349272B1 (fr) Composition veterinaire antiprolactinique destinee aux ruminants
EP0289186A2 (en) Process for increasing the growth rate and enhancing the feed efficiency of meat producing livestock
EP0766966A2 (en) Method of treating insulin resistance
IE922113A1 (en) Method of stimulating immune response
AU667300B2 (en) Immunostimulatory peptide from lactoferrin
MC1099A1 (fr) Médicament à base d'un polypeptide
JPS63303930A (ja) インシユリンおよびインシユリン誘導体の混合結晶
CN1723034A (zh) 治疗糖尿病的组合物和方法
Yen et al. Reduction of food consumption and body weight of normal and obese mice by chronic treatment with fluoxetine: a serotonin reuptake inhibitor
US4223017A (en) Biologically active amides
FR2575655A1 (fr) Utilisation d'un interferon a faibles doses notamment pour regler l'appetit et l'efficacite de l'utilisation des aliments
JPS60120995A (ja) 新規アミノ酸誘導体の製法
CN111514279A (zh) 神经营养因子3在制备治疗男性性腺功能减退症的药物中的应用
FR2471189A1 (fr) Procede de preparation d'un agent anti-tumoral comprenant un composant cellulaire de streptococcus pyogenes
EP1409531B1 (fr) L'heterocarpine, une proteine fixant le ghrh humain
FR2572936A1 (fr) Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leurs production et utilisations

Legal Events

Date Code Title Description
YP Annual fee paid